Historical record - last NADAC effective date: 2/17/2021

Product Information

BUPROPION HCL SR 200 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.1990 per EA under NDC 69097087903. Its NADAC has been published 233 times since Sep 14, 2016.

FDA first approved this application on Feb 9, 2016.

BUPROPION HCL SR 200 MG TABLET

Bupropion Hydrochloride
$0.1990per EA

Strength

200 mg/1

Manufacturer

Cipla USA Inc.

NDC

69097087903

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

2/17/2021

Active Ingredients

BUPROPION HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA206674

FDA Approved

2/9/2016

On Market Since

7/25/2016

Pharmacological Classes

Aminoketone
Dopamine Uptake Inhibitors
Increased Dopamine Activity
Increased Norepinephrine Activity
Norepinephrine Uptake Inhibitors

Price Statistics

The NADAC for BUPROPION HCL SR 200 MG TABLET has been published 233 times since Sep 14, 2016, and over the history we have for it it has declined 40.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1990 per EA
All-time high$0.3490 (Oct 12, 2016)
All-time low$0.1990 (Feb 17, 2021)
Median price$0.2424
Average price$0.2555
Largest weekly change-15.6% (Jul 17, 2019)
Weeks tracked233
Tracking sinceSep 14, 2016

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-40.6%

Last surveyed Feb 24, 2021 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Bupropion Hydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of BUPROPION HCL SR 200 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL SR 200 MG TABLET, manufactured by Cipla USA Inc., is $0.1990 per EA (NDC 69097087903), effective Feb 24, 2021.

How has the price of BUPROPION HCL SR 200 MG TABLET changed over time?

Over the history we have for it, the NADAC for BUPROPION HCL SR 200 MG TABLET has declined 40.6%. It has been tracked across 233 weekly CMS publications since Sep 14, 2016.

What are the highest and lowest recorded NADAC prices for BUPROPION HCL SR 200 MG TABLET?

Since Sep 14, 2016, the NADAC for BUPROPION HCL SR 200 MG TABLET has ranged from a low of $0.1990 (Feb 17, 2021) to a high of $0.3490 (Oct 12, 2016), with a median of $0.2424 per EA.

Are there cheaper alternatives to BUPROPION HCL SR 200 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of BUPROPION HCL SR 200 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures BUPROPION HCL SR 200 MG TABLET?

BUPROPION HCL SR 200 MG TABLET (NDC 69097087903) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.